Blood plasma was Incubated with 50 mM AAPH [2,2'-azobis-(2-amidinopropane) hydrochloride] in the absence or presence of catechins (5–100 μM). Lipid oxidation was evaluated by measuring the formation of 2-thiobarbituric acid reactive substances (TBARS). The concentration of α-tocopherol (AT), β-carotene (BC), ascorbic acid (AA), and catechins was determined by reverse phase high performance liquid chromatography (HPLC) with electrochemical detection. All the assayed catechins inhibited plasma TBARS formation. Based on the calculated IC50, the order of effectiveness was: epicatechin gallate (ECG) > epigallocatechin gallate (EGCG) > epigallocatechin (EGC) > epicatechin (EC) > catechin (C). Catechins protected plasma AT and BC from AAPH-mediated oxidation. The order of effectiveness for AT protection was ECG > EGCG > EC = C > EGC; and for BC protection, the order was EGCG > ECG > EGC > > EC > C. The addition of catechins modified the kinetics of TBARS formation and AT depletion, but the rate of AA depletion was not affected. Catechin oxidation did not start until the complete depletion of AA, and it preceded AT depletion. These results indicate that catechins are effective antioxidants in human blood plasma, delaying the lipid oxidation and depletion of endogenous lipid-soluble antioxidants (AT and BC).
Get full access to this article
View all access options for this article.
References
1.
HertogMGL, KroumhoutD, AravanisC, BlackburnH, BuzinaR, FidanzaF, GiampaoliS, JansenA, MenottiA, NedeljkovicS, PekkarinenM, SimicBS, ToshimaH, FeskensEJM, HollmanPCH, KatanMB. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med155: 381–386, 1995.
2.
HertogMGL, FeskensEJM, HollmanPCH, KatanMB, KroumhoutD.Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet342: 1007–1011, 1993.
3.
KeliSO, HertogMGL, FeskensEJM, KroumhoutD.Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen study. Arch Intern Med156: 637–642, 1996.
4.
RenaudS, de LorgerilM.Wine, alcohol, platelets, and French paradox for coronary heart disease. Lancet339: 1523–1526, 1992.
5.
FrankelEN, KannerJ, GermanJB, ParksE, KinsellaJE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet341: 454–457, 1993.
6.
HollmannPCH, KatanMB. Dietary flavonoids: Intake, health effects, and bioavailability. Food Chem Toxicol37: 937–942, 1999.
7.
Rice-EvansCA, MillerNJ, BolwellPG, BramleyPM, PridhamJB. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res22: 375–383, 1995.
8.
VinsonJA, DabbaghYA, SerryMM, JangJ.Plant flavonoids, especially tea flavonols, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agric Food Chem43: 2800–2802, 1995.
9.
FrankelEN, WaterhouseAL, TeissedrePL. Principal phenolic phyto-chemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem43: 890–893, 1995.
10.
FragaCG, MartinoVS, FerraroGE, CoussioJD, BoverisA.Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol36: 717–720, 1987.
11.
TeraoJ, PiskulaM, YaoQ.Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Arch Biochem Biophys308: 278–284, 1994.
12.
HertogMGL, HollmanPCH, van der PutteB.Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem41: 1242–1246, 1993.
13.
AdamsonGE, LazarusSA, MitchellAE, PriorRL, CaoG, JacobsPH, KremersBG, HammerstoneJF, RuckerRB, RitterKA, SchmitzHH. HPLC method for the quantification of procyanidins in cocoa and chocolate samples and correlation to total antioxidant capacity. J Agric Food Chem47: 4184–4188, 1999.
SteinbergD, ParthasarathyS, CarewTE, KhooJC, WitztumJL. Modifications of low-density lipoprotein that increases its atherogenicity. New Engl J Med320: 915–924, 1989.
16.
EsterbauerH, GebickiJ, PuhlH, JürgensG.The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med13: 341–390, 1992.
17.
WitztumJL. The oxidation hypothesis of atherosclerosis. Lancet344: 793–795, 1994.
18.
StephensNG, ParsonsA, SchofieldPM, KellyF, CheesemanK, MitchinsonMJ, BrownMJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet347: 781–786, 1996.
19.
RimmEB, StampferMJ, AscherioA, GiovannucciE, GolditzGA, WillettWGN. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med328: 1450–1456, 1993.
20.
Rice-EvansCA, MillerNJ, PagangaG.Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med20: 933–956, 1996.
21.
StockerR, FreiB.Endogenous antioxidant defences in human blood plasma. In: SiesH Ed. Oxidative Stress: Oxidants and Antioxidants. London: Academic Press, pp 213–243, 1991.
22.
NikiE.Free radical initiators as source of water or lipid soluble peroxyl radicals. Meth Enzymol186: 100–108, 1990.
23.
FragaCG, LeibovitzBE, TappelAL. Lipid peroxidation measured as thiobarbituric acid reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes. Free Radic Biol Med4: 155–161, 1988.
24.
MotchnikPA, FreiB, AmesBN. Measurements of antioxidants in human blood plasma. Meth Enzymol234: 269–279, 1994.
25.
LykkesfeldtJ, LoftS, PoulsenHE. Determination of ascorbic acid and dehydroascorbic acid by high performance liquid chromatography with coloumetric detection: Are they reliable biomarkers of oxidative stress?Anal Biochem229: 329–335, 1995.
SalahN, MillerNJ, PagangaG, TijburjL, BolwellGP, Rice-EvansCA. Polyphenols flavonols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys322: 339–346, 1995.
28.
LotitoSB, FragaCG. (+)-Catechin as antioxidant: Mechanisms preventing human plasma oxidation and activity in red wines. Biofactors10: 125–130, 1999.
29.
JovanovicSV, SteenkenS, TosicM, MarjanovicB, SimicM.Flavonoids as antioxidants. J Am Chem Soc116: 4846–4851, 1994.
30.
BorsW, MichelC, SchikoraS.Interaction of flavonoids with ascorbate and determination of their univalent redox potentials: A pulse radiolysis study. Free Radic Biol Med19: 45–52, 1995.
31.
BuettnerGR. The pecking order of free radicals and antioxidants: Lipid peroxidation, α-tocopherol, and ascorbate. Arch Biochem Biophys300: 535–543, 1993.
32.
J⊘rgensenLV, SkibstedLH. Flavonoid deactivation of ferrylmyoglobin in relation to ease of oxidation as determined by cyclic voltammetry. Free Radic Res28: 335–351, 1998.
33.
FreiB, StockerR, AmesBN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A85: 9748–9752, 1988.
34.
ZhuQY, HuangY, TsangD, ChenZ-Y.Regeneration of α-tocopherol in human low-density lipoprotein by green tea catechin. J Agric Food Chem47: 2020–2025, 1999.
35.
AzziA, BoscoboinikD, ClementS, OzerN, RicciarelliR, StockerA.Vitamin E mediated response of smooth muscle cells to oxidant stress. Diabetes Res Clin Pract45: 191–198, 1999.
36.
Brigelius-FloheR, TraberM.Vitamin E: Function metabolismFASEB J13:1145–1155, 1999.
37.
DonovanJL, BellJR, Kasim-KarakasS, GermanJB, WalzernRL, HansenRJ, WaterhouseAL. Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr129: 1662–1668, 1999.
38.
da SilvaEL, PiskulaMK, YamamotoN, MoonJ-H, TeraoJ.Quercetin metabolism inhibits copper ion-induced lipid peroxidation in rat plasma. FEBS Lett430: 405–408, 1998.
39.
ManachC, MorandC, CrespyV, DemigneC, TexierO, RegeratF, RemesyC.Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett426: 331–336, 1998.
